Advertisement

Advertisement

AU:CMB Stock Latest News

Cambium Bio Tightens Securities Trading Rules to Bolster Governance

Company AnnouncementsCambium Bio Tightens Securities Trading Rules to Bolster Governance

Cambium Bio issues 2.1 million new shares under disclosure relief

PremiumCompany Announcements

Cambium Bio issues 2.1 million new shares under disclosure relief

13d ago

Cambium Bio Plans Equity Placement of 2.1 Million Shares

PremiumCompany Announcements

Cambium Bio Plans Equity Placement of 2.1 Million Shares

15d ago

Cambium Bio Secures Premium-Priced Placement to Fund Phase 3 Dry Eye Trial

PremiumCompany Announcements

Cambium Bio Secures Premium-Priced Placement to Fund Phase 3 Dry Eye Trial

15d ago

Regeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings

PremiumCompany Announcements

Regeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings

1M ago

Regeneus Rectifies Late Substantial Shareholder Notice Filing

PremiumCompany AnnouncementsRegeneus Rectifies Late Substantial Shareholder Notice Filing

2M ago

Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular

Company Announcements

Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular

3M ago

Cambium Bio Director Increases Stake Through Share Placement

Company Announcements

Cambium Bio Director Increases Stake Through Share Placement

4M ago

Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance

PremiumCompany Announcements

Cambium Bio Issues New Shares Under Cleansing Notice, Affirms Regulatory Compliance

5M ago

Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares

PremiumCompany Announcements

Cambium Bio Seeks ASX Quotation for 4.36 Million New Shares

5M ago

Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

PremiumCompany Announcements

Cambium Bio Wins Strong Shareholder Backing for Capital-Raising Resolutions

5M ago

Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows

PremiumCompany Announcements

Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows

6M ago

Cambium Bio Plans Significant Share Placement to Raise Equity

PremiumCompany AnnouncementsCambium Bio Plans Significant Share Placement to Raise Equity

6M ago

Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control

Company Announcements

Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control

6M ago

Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular

Company Announcements

Cambium Bio Secures Funding and Advances Toward Phase 3 Trials for Elate Ocular

6M ago

Cambium Bio Plans Share Placement to Raise Fresh Capital

PremiumCompany Announcements

Cambium Bio Plans Share Placement to Raise Fresh Capital

7M ago

Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials

PremiumCompany Announcements

Cambium Bio Raises A$2.4m at Premium from Major Shareholder to Fund Phase 3 Dry Eye Trials

7M ago

Cambium Bio Advances with Strategic Partnerships and R&D Incentives

PremiumCompany Announcements

Cambium Bio Advances with Strategic Partnerships and R&D Incentives

9M ago

Cambium Bio Corrects Director’s Interest Notice Date

PremiumCompany Announcements

Cambium Bio Corrects Director’s Interest Notice Date

9M ago

Regeneus Ltd. Director Increases Stake with New Share Acquisition

PremiumCompany AnnouncementsRegeneus Ltd. Director Increases Stake with New Share Acquisition

10M ago

Regeneus Director Increases Stake with New Share Acquisition

Company Announcements

Regeneus Director Increases Stake with New Share Acquisition

10M ago

Cambium Bio Limited Issues New Shares

Company Announcements

Cambium Bio Limited Issues New Shares

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >